Innovative Approaches to Enhance and Measure Medication Adherence in Chronic Disease Management: A Review
Medical Science Monitor · 11.06.2024 · 30
DOI: 10.12659/msm.944605 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medical Science Monitor, online erschienen am 11.06.2024. Verfasst von Michał Gackowski und 3 weiteren Autor:innen. Beteiligte Einrichtung: Chair and Department of Pharmaceutical Technology, Poznań University of Medical Sciences, Poznań, Poland. Hauptthemen laut MEDLINE: Medication Adherence. Die Arbeit wurde bisher 23-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Chair and Department of Pharmaceutical Technology, Poznań University of Medical Sciences, Poznań, Poland.
- Department of Biopharmacy, Medical University of Łódź, Łódź, Poland.
- Pharmacy Practice and Pharmaceutical Care Division, Chair and Department of Pharmaceutical Technology, Poznań University of Medical Sciences, Poznań, Poland.
ORCID-Profile: Michał Gackowski, Magdalena Jasińska-Stroschein, Tomasz Osmałek, Magdalena Waszyk-Nowaczyk
Zitieren
APA
Gackowski, M., Jasińska-Stroschein, M., Osmałek, T., & Waszyk-Nowaczyk, M. (2024). Innovative Approaches to Enhance and Measure Medication Adherence in Chronic Disease Management: A Review. Medical Science Monitor, 30. https://doi.org/10.12659/msm.944605
Vancouver
Gackowski M, Jasińska-Stroschein M, Osmałek T, Waszyk-Nowaczyk M. Innovative Approaches to Enhance and Measure Medication Adherence in Chronic Disease Management: A Review. Medical Science Monitor. 2024;30. doi:10.12659/msm.944605
BibTeX
@article{Gackowski2024,
author = {Gackowski, Michał and Jasińska-Stroschein, Magdalena and Osmałek, Tomasz and Waszyk-Nowaczyk, Magdalena},
title = {Innovative Approaches to Enhance and Measure Medication Adherence in Chronic Disease Management: A Review},
journal = {Medical Science Monitor},
year = {2024},
volume = {30},
doi = {10.12659/msm.944605}
}
EUVIMED